Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGLN2 | Q96KS0 | 1/20 | 0.33 |
| ▸ | AKT1 | P31749 | 1/20 | 0.32 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | KIT | P10721 | 1/20 | 0.31 |
| ▸ | DPP8 | Q6V1X1 | 2/20 | 0.31 |
| ▸ | DPP9 | Q86TI2 | 2/20 | 0.31 |
| ▸ | PDE2A | O00408 | 2/20 | 0.30 |
| ▸ | ERN1 | O75460 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL34469743 | 0.94 | EGLN2 (0.34) | EGLN2AKT1CYP17A1PKMKIT | |
| SCHEMBL34469480 | 0.93 | EGLN2 (0.34) | EGLN2AKT1CYP17A1KITDPP8 | |
| SCHEMBL34470168 | 0.87 | EGLN2 (0.35) | EGLN2AKT1CYP17A1KITDPP8 | |
| SCHEMBL34469676 | 0.86 | AKT1 (0.41) | AKT1PKMKITPDE2A | |
| SCHEMBL34469753 | 0.82 | AKT1 (0.41) | AKT1PKMKITPDE2A | |
| SCHEMBL34470144 | 0.82 | AKT1 (0.35) | EGLN2AKT1PDE2A | |
| SCHEMBL34469468 | 0.79 | AKT1 (0.43) | AKT1PKMKITPDE2A | |
| SCHEMBL34469946 | 0.78 | AKT1 (0.42) | AKT1KITPDE2A | |
| SCHEMBL34470005 | 0.75 | AKT1 (0.43) | AKT1PKMKITPDE2A | |
| SCHEMBL34469432 | 0.72 | ERN1 (0.41) | EGLN2ERN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026090477-A1 | HELICASE INHIBITORS AND USES THEREOF | KIMIA THERAPEUTICS, INC. (US) | 2026-04-30 | — | — | WO | disclosed |